Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11). Revenue for the quarter came in at $9.09 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• BTIG Reiterates Neutral Rating on MaxCyte Inc. (MXCT)
• Palo Alto Networks (PANW) PT Raised to $400 at Benchmark
• Stocks expected to have increasing option volume: BA WBD PSKY MSTR MRNA